Non-Surgical Options for Managing Knee Osteoarthritis

2577 East 17th Street, Suite #18 Brooklyn, NY 11235

Knee osteoarthritis (OA) is among the most commonly diagnosed orthopedic conditions. For individuals living with OA, the associated discomfort may interfere with daily activities and affect overall well-being.

Typically, individuals over 40 experiencing knee pain from osteoarthritis, commonly referred to as arthritis, may be advised to pursue conservative measures such as physical therapy, nonsteroidal anti-inflammatory medications (NSAIDs), or corticosteroid or hyaluronate injections to help manage inflammation and discomfort. If these approaches do not lead to meaningful improvement, arthroscopic surgery may be considered to address damaged cartilage or tissue. When symptoms persist following these interventions, total knee replacement is often presented as the next step.

Alternative to knee replacement surgery for osteoarthritis

Numerous studies[2] evaluating the outcomes of typical orthopedic knee surgeries suggest that these procedures may offer limited benefit, especially for individuals over the age of 40. Even in younger patients, success is not universal. Some patients are unaware that surgery may not always be the most appropriate solution.

Read on to learn more about the Regenexx approach, which offers an alternative to knee replacement surgery for osteoarthritis. These procedures utilize interventional orthobiologics to support the body’s natural healing response, and they may help reduce pain and improve function. Treatment is delivered by physicians in the licensed Regenexx network and is customized to individual needs.

2577 East 17th Street
Suite #18
Brooklyn, NY 11235

Request an Appointment

Call to Schedule Schedule Online

Doctors

Dr. Ilana Etelzon is a highly skilled Pain Management Specialist with extensive experience in Interventional Pain and Musculoskeletal Medicine. Fellowship-trained, she emphasizes regenerative techniques and adopts a non-operative approach to pain management. Dr. Etelzon specializes in addressing a wide range of conditions, including lower back pain, sciatica, pinched nerves, neck pain, and musculoskeletal injuries related to overuse, sports, and arthritis. She employs advanced fluoroscopic and ultrasound-guided methods to ensure precise and effective treatments.

Dr. Etelzon is dedicated to breaking the cycle of pain by developing practical and personalized treatment plans in collaboration with her patients. Her approach begins with alleviating pain, followed by rehabilitation designed to prevent recurrence. The ultimate goal is to create an individualized strategy tailored to each patient’s needs, fostering long-term success and satisfaction.

With expertise in innovative, minimally invasive techniques, Dr. Etelzon focuses on treatments that promote the body’s natural ability to heal and repair. Her methods have been met with high success rates, as evidenced by the positive feedback from her patients.

Dr. Etelzon is an active member of leading professional organizations, including the American Society of Interventional Pain Physicians (ASIPP), Spine Intervention Society (SIS), North American Spine Society (NASS), and the American Academy of Physical Medicine and Rehabilitation (AAPMR). She has contributed to numerous articles on pain management, regenerative medicine, sports medicine, and cardiac rehabilitation. In addition to her clinical work, Dr. Etelzon remains involved in research and enjoys teaching and mentoring residents and students.

View Full Profile

Areas treated: Cervical Spine (Not Upper Cervical or CCI)*, Elbow, Foot & Ankle, Hand & Wrist, Hip, Knee, Lumbar Spine, Shoulder, Thoracic Spine

Areas Treated

Cervical Spine (Not Upper Cervical or CCI)*, Elbow, Foot & Ankle, Hand & Wrist, Hip, Knee, Lumbar Spine, Shoulder, Thoracic Spine

*This provider is NOT authorized by Regenexx to treat the C0-C1 or C1-C2 levels of the neck or CCI (craniocervical instability).

How Does the Regenexx Approach Work for Knee Osteoarthritis?

Physicians in the licensed Regenexx network at Pain Doctors Medical in Brooklyn, New York, utilize Regenexx procedures as part of an approach called interventional orthobiologics. This minimally invasive option compared to knee surgery uses image-guided injection of the individual’s own bone marrow concentrate directly into the joint.

The cellular elements in the concentrate may support the body’s natural healing response at the injury site and may help reduce the need for surgery.

Physicians in the licensed Regenexx network at Pain Doctors Medical in Brooklyn, New York, conduct a thorough evaluation of movement patterns and may use ultrasound imaging to view the joint’s internal structures in real time. This approach provides a clearer understanding of what may be the cause of pain, how joint function is impacted, and what underlying issues are contributing to the condition.

Following this evaluation, the physician will develop a customized treatment plan. Recommended procedures may include:

Regenexx SD Injectate: A procedure using bone marrow concentrate, which contains stem cells, prepared according to Regenexx intellectual property.

Regenexx SCP Injectate: A proprietary formulation of platelet-rich plasma (PRP) that is more concentrated than PRP produced by typical bedside centrifuge devices.

Regenexx PL Injectate: Platelet lysate, a specialized derivative of platelet-rich plasma (PRP).

See how Regenexx helped Stephanie with her chronic pain from knee osteoarthritis.

Am I a candidate?

Note: Like all medical procedures, Regenexx procedures have a success and failure rate. Not all patients will experience the same results.

 

Below are MRI images from two individuals who underwent procedures using Regenexx lab processes for knee osteoarthritis. Scroll the arrow to the right to view the MRI of the knee joint before treatment; the white/lighter area may indicate areas of joint degeneration. Scroll to the left to view the MRI of the knee joint following the procedure.

Patient 1 MRI: 51 years old

Patient 2 MRI: 46 years old

Patient 1:

This individual experienced limited improvement following a microfracture procedure and was unable to resume many daily activities. A procedure using a percutaneous injection of autologous cells processed using Regenexx lab methods was later performed. Following the procedure, the individual reported returning to routine functional activities.

Patient 2:

This individual underwent arthroscopic debridement, during which a 3 cm by 4 cm osteochondral defect on the medial femur was identified. Approximately 1.5 years after surgery, the individual received a percutaneous procedure involving autologous cells processed using Regenexx lab methods. Subsequent to the procedure, the individual reported resuming full functional activities.

Am I a candidate?

Request an Appointment

TO TOP